Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01137760 · ClinicalTrials.gov registry record · NA

Galactooligosaccharide, Immune Strength, and Digestive Health

A NA study of Healthy, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
427
Enrollment target
1
Study location

NCT01137760 is a NA study of Healthy that has completed, run by University of Florida. The registered enrollment target is 427 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01137760, a NA study of Healthy, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
427 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to determine whether a functional fiber, galactooligosaccharide, can help maintain immune strength and digestive health in undergraduate students who are undergoing an academic stress (i.e., final exams). Subjects will be asked to consume the fiber or placebo each day for eight weeks. Immune and gastrointestinal health will be evaluated via daily questionnaires obtained from 420 students and from the collection of fecal samples in a subgroup of students.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Sucrose
  • DIETARY_SUPPLEMENT Galactooligosaccharide

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 427 participants
Start Date 2009-10
Est. Completion 2010-01
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01137760

The ClinicalTrials.gov registry entry for NCT01137760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 427 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (34% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Sucrose is the first listed.

NCT01137760 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01137760 about?

NCT01137760 is a clinical study titled "Galactooligosaccharide, Immune Strength, and Digestive Health". The purpose of this research study is to determine whether a functional fiber, galactooligosaccharide, can help maintain immune strength and digestive health in undergraduate students who are undergoing an academic stress (i.e., final exams). Subjects will be asked to consume the fiber or placebo ea...

What is the current status of trial NCT01137760?

This trial is currently completed. It is a NA study. The enrollment target is 427 participants. The study started on 2009-10. Estimated completion is 2010-01.

What conditions does trial NCT01137760 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01137760?

The interventions under investigation include: Sucrose (DIETARY_SUPPLEMENT), Galactooligosaccharide (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01137760?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01137760 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.